Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly sales of $6.20 million which met the analyst consensus estimate. This is a 51.92 percent increase over sales of $4.08 million the same period last year.
Tim Cook Doesn’t See A Path Back To Chip Vendors: ‘We Like To Own The Primary Technologies In The Products That We Ship’
Apple CEO Tim Cook emphasizes the company's commitment to in-house silicon development, stating that owning the primary technologies in their products, especially chips, is strategic and beneficial, with no plans to revert to external chip vendors.
